Recently we have reported an initial investigation on 4-thiazolidinone derivatives active as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the context of our search for new candidates for the treatment of type 2 diabetes mellitus and its complications [5]. Here, AKR1B1 is linked to diabetes mellitus.